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Background: Long-term outcomes of endovascular therapy (EVT) for chronic total occlusion (CTO) of the superficial femoral artery (SFA) remain to 
be undetermined.
Methods: From June 2004 to June 2010, consecutive 144 patients (163 limbs, 183 lesions) with CTO in SFA underwent EVT. Clinical events of 
these patients were retrospectively determined. During the follow-up periods of 36.4±20.9 months, primary/secondary patency and major adverse 
events (MAE: death, major amputation, restenosis, target lesion revascularization [TLR]), were examined.
Results: Mean age was 71.7 years. Patients with diabetes mellitus and on hemodialysis were included in 80 (55.6%) and in 34 (23.6%), 
respectively. TASC 2 lesion classifications were type A/B in 31 lesions, C in 52 lesions, and D in 100 lesions. Lesion success was achieved in 157 
lesions in 130 patients (85.8%). Self-expandable stent was implanted in 90.2%. Bi-directional approach was performed in 64 procedures (33.9%). 
Procedural complications were as follows; pseudo aneurhythm, 4 (2.2%); cholesterol embolization, 2 (1.1%); large hematoma (required delay of 
hospitalization), 1 (0.5%); total complications, 7 (3.8%). Primary, secondary patency rate and MAE free survival were shown in Figure as Kaplan-
Meier Curve.
Conclusions: EVT for SFA CTO could be performed safely. Long-term results of EVT for SFA CTO were favorable.
 
